Back to top

moving-average-crossover: Archive

Zacks Equity Research

Strength Seen in Amicus Therapeutics (FOLD): Can Its 6.4% Jump Turn into More Strength?

Amicus Therapeutics (FOLD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

FOLDNegative Net Change TECHPositive Net Change

Zacks Equity Research

Strength Seen in Intellia Therapeutics (NTLA): Can Its 29.8% Jump Turn into More Strength?

Intellia Therapeutics (NTLA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

NTLANegative Net Change CGONPositive Net Change

Zacks Equity Research

Amkor Technology (AMKR) Moves 9.5% Higher: Will This Strength Last?

Amkor Technology (AMKR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

AMKRNegative Net Change LASRPositive Net Change

Zacks Equity Research

Jefferies (JEF) Soars 5.8%: Is Further Upside Left in the Stock?

Jefferies (JEF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

JEFPositive Net Change BXNegative Net Change

Zacks Equity Research

Strength Seen in American Superconductor (AMSC): Can Its 6.6% Jump Turn into More Strength?

American Superconductor (AMSC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

AMSCPositive Net Change LFUSPositive Net Change

Zacks Equity Research

Strength Seen in Rambus (RMBS): Can Its 10.1% Jump Turn into More Strength?

Rambus (RMBS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

RMBSPositive Net Change NVTSNegative Net Change

Zacks Equity Research

Camtek (CAMT) Moves 13.7% Higher: Will This Strength Last?

Camtek (CAMT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

CAMTPositive Net Change AEHRNegative Net Change

Zacks Equity Research

Arcturus Therapeutics (ARCT) Surges 8.7%: Is This an Indication of Further Gains?

Arcturus Therapeutics (ARCT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

ARCTPositive Net Change ANIKPositive Net Change

Zacks Equity Research

Strength Seen in Luxfer (LXFR): Can Its 5.4% Jump Turn into More Strength?

Luxfer (LXFR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

LXFRPositive Net Change HLIOPositive Net Change

Zacks Equity Research

Mirion Technologies (MIR) Surges 8.4%: Is This an Indication of Further Gains?

Mirion Technologies (MIR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

MIRPositive Net Change CRCTPositive Net Change

Zacks Equity Research

StepStone Group (STEP) Soars 8.8%: Is Further Upside Left in the Stock?

StepStone Group (STEP) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

STEPPositive Net Change SOFINegative Net Change

Zacks Equity Research

National Vision (EYE) Surges 6.4%: Is This an Indication of Further Gains?

National Vision (EYE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

EYEPositive Net Change PGPositive Net Change

Zacks Equity Research

Green Plains (GPRE) Soars 7.0%: Is Further Upside Left in the Stock?

Green Plains (GPRE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

GPREPositive Net Change PPGNegative Net Change

Zacks Equity Research

Lyft (LYFT) Surges 13.1%: Is This an Indication of Further Gains?

Lyft (LYFT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

GOOGLPositive Net Change LYFTPositive Net Change DASHPositive Net Change

Zacks Equity Research

Montes Archimedes Acquisition (ROIV) Surges 7.8%: Is This an Indication of Further Gains?

Montes Archimedes Acquisition (ROIV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

ROIVPositive Net Change ADCTPositive Net Change

Zacks Equity Research

Strength Seen in Xencor (XNCR): Can Its 7.3% Jump Turn into More Strength?

Xencor (XNCR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

XNCRPositive Net Change ACRSPositive Net Change

Zacks Equity Research

CG Oncology, Inc. (CGON) Moves 5.5% Higher: Will This Strength Last?

CG Oncology, Inc. (CGON) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

CGONPositive Net Change GERNPositive Net Change

Zacks Equity Research

Hologic (HOLX) Soars 7.7%: Is Further Upside Left in the Stock?

Hologic (HOLX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

HOLXPositive Net Change ALCPositive Net Change

Zacks Equity Research

Performance Food (PFGC) Surges 3.8%: Is This an Indication of Further Gains?

Performance Food (PFGC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

PFGCPositive Net Change SFMNegative Net Change

Zacks Equity Research

Tango Therapeutics (TNGX) Soars 7.8%: Is Further Upside Left in the Stock?

Tango Therapeutics (TNGX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

TNGXPositive Net Change KRYSPositive Net Change

Zacks Equity Research

Strength Seen in Chord Energy Corporation (CHRD): Can Its 4.0% Jump Turn into More Strength?

Chord Energy Corporation (CHRD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

CHRDPositive Net Change PRNegative Net Change

Zacks Equity Research

Geopark (GPRK) Soars 5.8%: Is Further Upside Left in the Stock?

Geopark (GPRK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

GPRKPositive Net Change MGYPositive Net Change

Zacks Equity Research

Enova International (ENVA) Soars 3.8%: Is Further Upside Left in the Stock?

Enova International (ENVA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

ENVANegative Net Change WRLDPositive Net Change

Zacks Equity Research

Strength Seen in Atlanticus (ATLC): Can Its 5.5% Jump Turn into More Strength?

Atlanticus (ATLC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

ATLCNegative Net Change WTNegative Net Change